These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 20333789)

  • 21. A clinical study of Wilson's disease: The experience of a single Egyptian Paediatric Hepatology Unit.
    El-Karaksy H; Fahmy M; El-Raziky MS; El-Hawary M; El-Sayed R; El-Koofy N; El-Mougy F; El-Hennawy A; El-Shabrawi M
    Arab J Gastroenterol; 2011 Sep; 12(3):125-30. PubMed ID: 22055589
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Treatment of Wilson's disease with zinc. VI. Initial treatment studies.
    Brewer GJ; Yuzbasiyan-Gurkan V; Lee DY; Appelman H
    J Lab Clin Med; 1989 Dec; 114(6):633-8. PubMed ID: 2592853
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Wilson disease: Canadian perspectives on presentation and outcomes from an adult ambulatory setting.
    Moores A; Fox S; Lang A; Hirschfield GM
    Can J Gastroenterol; 2012 Jun; 26(6):333-9. PubMed ID: 22720274
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Diagnostic criteria for acute liver failure due to Wilson disease.
    Eisenbach C; Sieg O; Stremmel W; Encke J; Merle U
    World J Gastroenterol; 2007 Mar; 13(11):1711-4. PubMed ID: 17461475
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Treatment with D-penicillamine or zinc sulphate affects copper metabolism and improves but not normalizes antioxidant capacity parameters in Wilson disease.
    Gromadzka G; Karpińska A; Przybyłkowski A; Litwin T; Wierzchowska-Ciok A; Dzieżyc K; Chabik G; Członkowska A
    Biometals; 2014 Feb; 27(1):207-15. PubMed ID: 24368744
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Zinc treatment prevents lipid peroxidation and increases glutathione availability in Wilson's disease.
    Farinati F; Cardin R; D'inca R; Naccarato R; Sturniolo GC
    J Lab Clin Med; 2003 Jun; 141(6):372-7. PubMed ID: 12819634
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Uneven distribution of hepatic copper concentration and diagnostic value of double-sample biopsy in Wilson's disease.
    Liggi M; Mais C; Demurtas M; Sorbello O; Demelia E; Civolani A; Demelia L
    Scand J Gastroenterol; 2013 Dec; 48(12):1452-8. PubMed ID: 24164422
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Liver pathology in Wilson's disease: From copper overload to cirrhosis.
    Gerosa C; Fanni D; Congiu T; Piras M; Cau F; Moi M; Faa G
    J Inorg Biochem; 2019 Apr; 193():106-111. PubMed ID: 30703747
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Idiopathic copper toxicosis: is abnormal copper metabolism a primary cause of this disease?
    Harada M; Honma Y; Yoshizumi T; Kumamoto K; Oe S; Harada N; Tanimoto A; Yabuki K; Karasuyama T; Yoneda A; Shibata M
    Med Mol Morphol; 2020 Mar; 53(1):50-55. PubMed ID: 31161407
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Bis-choline tetrathiomolybdate in patients with Wilson's disease: an open-label, multicentre, phase 2 study.
    Weiss KH; Askari FK; Czlonkowska A; Ferenci P; Bronstein JM; Bega D; Ala A; Nicholl D; Flint S; Olsson L; Plitz T; Bjartmar C; Schilsky ML
    Lancet Gastroenterol Hepatol; 2017 Dec; 2(12):869-876. PubMed ID: 28988934
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Wilson disease with visceral leishmaniasis: an extremely uncommon presentation.
    Pandey K; Sinha PK; Das VN; Kumar N; Verma N; Bimal S; Lal CS; Topno RK; Singh D; Verma RB; Bhattacharya SK; Das P
    Am J Trop Med Hyg; 2007 Sep; 77(3):560-1. PubMed ID: 17827379
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The effect of long term treatment with penicillamine on the copper content in the liver in patients with Wilson's disease.
    Marecek Z; Heyrovský A; Volek V
    Acta Hepatogastroenterol (Stuttg); 1975 Oct; 22(5):292-6. PubMed ID: 1199668
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Persistence with treatment for Wilson disease: a retrospective study.
    Masełbas W; Członkowska A; Litwin T; Niewada M
    BMC Neurol; 2019 Nov; 19(1):278. PubMed ID: 31718567
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prognosis of Wilsonian chronic active hepatitis.
    Schilsky ML; Scheinberg IH; Sternlieb I
    Gastroenterology; 1991 Mar; 100(3):762-7. PubMed ID: 1993498
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Therapy of Wilson disease].
    Smolarek C; Stremmel W
    Z Gastroenterol; 1999 Apr; 37(4):293-300. PubMed ID: 10378366
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Unusual liver MR findings of Wilson's disease in an asymptomatic 2-year-old girl.
    Ko S; Lee T; Ng S; Lin J; Cheng Y
    Abdom Imaging; 1998; 23(1):56-9. PubMed ID: 9437064
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Wilson's disease treatment by triethylene tetramine dihydrochloride (trientine, 2HCl): long-term observations.
    Morita J; Yoshino M; Watari H; Yoshida I; Motohiro T; Yamashita F; Okano Y; Hashimoto T
    Dev Pharmacol Ther; 1992; 19(1):6-9. PubMed ID: 1307347
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Wilson disease: an update].
    Seo JK
    Korean J Hepatol; 2006 Sep; 12(3):333-63. PubMed ID: 16998287
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Rare, but important chronic liver diseases].
    Maier KP
    Praxis (Bern 1994); 2002 Nov; 91(48):2077-85. PubMed ID: 12508671
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Wilson disease in children: analysis of 57 cases.
    Manolaki N; Nikolopoulou G; Daikos GL; Panagiotakaki E; Tzetis M; Roma E; Kanavakis E; Syriopoulou VP
    J Pediatr Gastroenterol Nutr; 2009 Jan; 48(1):72-7. PubMed ID: 19172127
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.